Insilico Medicine Raises $60 Million In Series D Financing To Advance Pipeline And Launch Ai-Powered Drug Discovery Robotics Laboratory
Amount Raised
$60 Million
Round Type
Series D
New YorkBiotechnologyDescription
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Insilico Medicine that raised within 45 days of this round, from Fundz verified event records.
- Empatica raised $26M on July 21, 2022.
- 22nd Century raised $35M on July 21, 2022.
- Exact Imaging raised an undisclosed amount (Funding Round) on July 21, 2022.
- Camp4 Therapeutics Corp raised $100M (Series B) on July 20, 2022.
- Sequana Medical raised $11M (Debt Financing) on July 20, 2022.
- KaloCyte raised an undisclosed amount on July 20, 2022.
Who to call at Insilico Medicine, and when
A new round usually means Insilico Medicine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Insilico Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Insilico Medicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Insilico Medicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Insilico Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Insilico Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.